NHS: Drugs

Department of Health and Social Care written question – answered at on 27 December 2023.

Alert me about debates like this

Photo of Lord Shinkwin Lord Shinkwin Conservative

To ask His Majesty's Government whether they intend to publish (1) national-level, and (2) NHS trust-level, key performance indicators on missed doses and delayed treatment initiation to monitor the performance and safety of homecare medicines services.

Photo of Lord Shinkwin Lord Shinkwin Conservative

To ask His Majesty's Government whether they have assessed the difference between a missed delivery and a missed dose of medicine in terms of their policy implications as part of the National Homecare Medicines Committee’s review of national homecare medicines services.

Photo of Lord Markham Lord Markham The Parliamentary Under-Secretary for Health and Social Care

NHS England is committed to improving patient safety and understanding the important role data can play in driving quality improvement.

There are currently national key performance metric definitions available as part of the Royal Pharmaceutical Society Homecare Services Professionals Standards which include definitions criteria on the number of failed deliveries, missed doses and patient safety incidents. Patients routinely hold approximately two weeks’ worth of supply of medicines to minimise the risk of a missed or delayed delivery becoming a missed dose.

NHS England has been carrying out an internal review on homecare medicines services. Extensive stakeholder engagement has been undertaken on revising the national key performance indicators (KPIs) and a transition to new KPIs will begin in spring 2024, with full reporting expected by autumn 2024.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.